Testing a hepatitis C screening tool in the emergency department
Part of Digestive system, Immune system & allergy, Infections clinical trials.
This study tests a new tool that helps emergency department doctors identify patients who might have hepatitis C. If it works, it could lead to more people getting tested and treated for the virus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 79 years old
- Be medically stable (not in a critical or unstable condition)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how emergency department patients feel about a new, quick test for hepatitis C. If you have tested positive for hepatitis C antibodies but haven't had a follow-up test to confirm an active infection, you might be able to join and share your thoughts on this new testing approach.
This trial studies point-of-care (on-site) testing to find hepatitis C in adults who are at higher risk. If hepatitis C is found, earlier detection can help you get connected to care sooner.
This trial tests a convenient way to screen people who use drugs or are in vulnerable situations for hepatitis B, C, and HIV using rapid tests and a liver scanner. The goal is to see if offering these tests in community settings (like shelters or mobile clinics) is acceptable and works well.
This study tests a new way to help primary care doctors remember to screen their adult patients for HIV, hepatitis B, and hepatitis C. It aims to make sure more people get tested for these infections during regular checkups.
This study offers a one-stop approach to testing and treating hepatitis C during a single emergency room visit. If you test positive, you may receive treatment right away, potentially avoiding extra appointments and helping you get cured faster.
This trial tests whether a patient-friendly electronic app given in the emergency department can increase what you know about hepatitis C and help you move to the next steps of care. It may be most helpful for people who are hepatitis C–positive but don’t yet have clear information about their status.
Hear when a new Hepatitis C Virus (HCV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.